首页 > 最新文献

Turk Onkoloji Dergisi-Turkish Journal of Oncology最新文献

英文 中文
The Relationship between Pre-operative Anti-thyroglobulin Antibody Level and Lymph Node Metastasis and Recurrence in Differentiated Thyroid Cancer 分化型甲状腺癌术前抗甲状腺球蛋白抗体水平与淋巴结转移及复发的关系
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3615
M. Can
{"title":"The Relationship between Pre-operative Anti-thyroglobulin Antibody Level and Lymph Node Metastasis and Recurrence in Differentiated Thyroid Cancer","authors":"M. Can","doi":"10.5505/tjo.2022.3615","DOIUrl":"https://doi.org/10.5505/tjo.2022.3615","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological Markers in Adult Glial Tumors: A Single-Center Experience and The Utility of the Classification System 成人神经胶质肿瘤的流行病学标志物:单中心经验和分类系统的应用
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2021.3441
Eyup Bayatli
{"title":"Epidemiological Markers in Adult Glial Tumors: A Single-Center Experience and The Utility of the Classification System","authors":"Eyup Bayatli","doi":"10.5505/tjo.2021.3441","DOIUrl":"https://doi.org/10.5505/tjo.2021.3441","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71124358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanocrystal’s Formulation of Biological Response Modifier P-MAPA on Bladder Cancer Compared to Bacillus Calmette-Guerin Immunomodulator 纳米晶体制备的生物反应调节剂P-MAPA治疗膀胱癌与卡介苗免疫调节剂的比较
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3421
W. Fávaro
{"title":"Nanocrystal’s Formulation of Biological Response Modifier P-MAPA on Bladder Cancer Compared to Bacillus Calmette-Guerin Immunomodulator","authors":"W. Fávaro","doi":"10.5505/tjo.2022.3421","DOIUrl":"https://doi.org/10.5505/tjo.2022.3421","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dosimetric Comparison of Three-Dimensional Conformal Radiotherapy with Hybrid Intensity-Modulated Radiotherapy Techniques for Treatment of Locally Advanced Lung Cancer 三维适形放疗与混合调强放疗治疗局部晚期肺癌的剂量学比较
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3564
özge söyünmez
{"title":"Dosimetric Comparison of Three-Dimensional Conformal Radiotherapy with Hybrid Intensity-Modulated Radiotherapy Techniques for Treatment of Locally Advanced Lung Cancer","authors":"özge söyünmez","doi":"10.5505/tjo.2022.3564","DOIUrl":"https://doi.org/10.5505/tjo.2022.3564","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stereotactic Radiosurgery to the Resection Cavity in Patients with Brain Metastases: Patterns of Failure and Prognostic Factors 立体定向放射治疗脑转移瘤患者的切除腔:失败模式和预后因素
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3591
U. Yilmaz
{"title":"Stereotactic Radiosurgery to the Resection Cavity in Patients with Brain Metastases: Patterns of Failure and Prognostic Factors","authors":"U. Yilmaz","doi":"10.5505/tjo.2022.3591","DOIUrl":"https://doi.org/10.5505/tjo.2022.3591","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Outcome and Characteristics of Turkish Breast Cancer Patients who had SARS-Cov-2 Infection 土耳其乳腺癌合并SARS-Cov-2感染患者的临床结局和特点
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3692
A. Isiklar
OBJECTIVE COVID-19 pandemic has placed an unprecedented burden on health-care system. Patients with cancer are reported to have a higher risk of infection and a more complicated COVID-19 course. Breast cancer (BC) is the most common cancer in women in Turkey. We report clinical outcomes and characteristics of patients with COVID-19 who were on treatment for BC at our center. METHODS We reviewed medical records of BC patients who had COVID-19 between July 2020 and 2021 at our center. We recorded pathological, clinical, treatment characteristics, and the clinical outcome of COVID-19 infection. RESULTS A total 82 BC patients had COVID-19 between July 2020 and 2021. All patients were female, with a median age of 49 (43-64 years). 85% of all patients had early and 14.6% of them had advanced stage BC. COVID-19 had a mild clinical course in 73%, hospitalization was required in 27% of patients. Twenty-five patients who required hospitalization were discharged and three patients died due to COVID-19. All of the patients who died from COVID-19 had metastatic BC (p=0.002). Metastatic disease (p=0.002) and chemotherapy within 7 days of COVID-19 diagnosis (p=0.024) have been associated with increased mortality. CONCLUSION Majority of BC patients with COVID-19 have a mild course, patients with risk factors that increase mortality should be followed more carefully.
2019冠状病毒病大流行给卫生保健系统带来了前所未有的负担。据报道,癌症患者感染的风险更高,COVID-19的病程也更复杂。乳腺癌(BC)是土耳其妇女中最常见的癌症。我们报告了在我们中心接受BC治疗的COVID-19患者的临床结果和特征。方法:我们回顾了2020年7月至2021年7月在我们中心感染COVID-19的BC患者的医疗记录。我们记录了COVID-19感染的病理、临床、治疗特点和临床转归。结果在2020年7月至2021年7月期间,共有82例BC患者感染了COVID-19。所有患者均为女性,中位年龄为49岁(43-64岁)。85%的患者为早期BC, 14.6%为晚期BC。73%的患者临床病程轻微,27%的患者需要住院治疗。25名需要住院治疗的患者出院,3名患者死亡。所有死于COVID-19的患者都有转移性BC (p=0.002)。转移性疾病(p=0.002)和COVID-19诊断后7天内的化疗(p=0.024)与死亡率增加相关。结论BC省新冠肺炎患者病程以轻症为主,对存在增加死亡率危险因素的患者应加强随访。
{"title":"Clinical Outcome and Characteristics of Turkish Breast Cancer Patients who had SARS-Cov-2 Infection","authors":"A. Isiklar","doi":"10.5505/tjo.2022.3692","DOIUrl":"https://doi.org/10.5505/tjo.2022.3692","url":null,"abstract":"OBJECTIVE COVID-19 pandemic has placed an unprecedented burden on health-care system. Patients with cancer are reported to have a higher risk of infection and a more complicated COVID-19 course. Breast cancer (BC) is the most common cancer in women in Turkey. We report clinical outcomes and characteristics of patients with COVID-19 who were on treatment for BC at our center. METHODS We reviewed medical records of BC patients who had COVID-19 between July 2020 and 2021 at our center. We recorded pathological, clinical, treatment characteristics, and the clinical outcome of COVID-19 infection. RESULTS A total 82 BC patients had COVID-19 between July 2020 and 2021. All patients were female, with a median age of 49 (43-64 years). 85% of all patients had early and 14.6% of them had advanced stage BC. COVID-19 had a mild clinical course in 73%, hospitalization was required in 27% of patients. Twenty-five patients who required hospitalization were discharged and three patients died due to COVID-19. All of the patients who died from COVID-19 had metastatic BC (p=0.002). Metastatic disease (p=0.002) and chemotherapy within 7 days of COVID-19 diagnosis (p=0.024) have been associated with increased mortality. CONCLUSION Majority of BC patients with COVID-19 have a mild course, patients with risk factors that increase mortality should be followed more carefully.","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dosimetric Evaluation of Total Body Irradiations with Helical Tomotherapy: Phantom Study 螺旋断层治疗的全身照射剂量学评价:幻影研究
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3722
G. Ucar Alveroglu
{"title":"Dosimetric Evaluation of Total Body Irradiations with Helical Tomotherapy: Phantom Study","authors":"G. Ucar Alveroglu","doi":"10.5505/tjo.2022.3722","DOIUrl":"https://doi.org/10.5505/tjo.2022.3722","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Restaging of Cervical Cancer Patients Treated with Adjuvant Radiotherapy According to FIGO 2018 and Suggestions for the Next Staging: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-004) 根据FIGO 2018对宫颈癌辅助放疗患者的再分期及下一步分期建议:土耳其放射肿瘤学会妇科组研究(TROD 04-004)
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3822
çağlayan selenge bedük esen
{"title":"Restaging of Cervical Cancer Patients Treated with Adjuvant Radiotherapy According to FIGO 2018 and Suggestions for the Next Staging: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-004)","authors":"çağlayan selenge bedük esen","doi":"10.5505/tjo.2022.3822","DOIUrl":"https://doi.org/10.5505/tjo.2022.3822","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiotoxicity in the Childhood Oncological Therapies 儿童肿瘤治疗中的心脏毒性
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.s1008
Beyza Aksu
{"title":"Cardiotoxicity in the Childhood Oncological Therapies","authors":"Beyza Aksu","doi":"10.5505/tjo.2022.s1008","DOIUrl":"https://doi.org/10.5505/tjo.2022.s1008","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of 18F-FDG PET/CT Findings and CA-125 Levels in Ovarian Cancer Staging 18F-FDG PET/CT表现及CA-125水平在卵巢癌分期中的研究
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3431
Reşit Akyel
{"title":"Investigation of 18F-FDG PET/CT Findings and CA-125 Levels in Ovarian Cancer Staging","authors":"Reşit Akyel","doi":"10.5505/tjo.2022.3431","DOIUrl":"https://doi.org/10.5505/tjo.2022.3431","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turk Onkoloji Dergisi-Turkish Journal of Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1